ANGLE plc
CelLBxHealth plc, a medical diagnostic company, develops cancer diagnostics products in the United Kingdom, Europe, North America, and internationally. The company develops Parsortix PC1 systems, a medical device for the capture and harvest of intact circulating tumour cells (CTCs) from metastatic breast cancer patient blood for subsequent user-validated downstream analysis; and Parsortix PR1 sys… Read more
ANGLE plc (ANPCF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2023: -0.140x
Based on the latest financial reports, ANGLE plc (ANPCF) has a cash flow conversion efficiency ratio of -0.140x as of June 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.50 Million) by net assets ($32.07 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
ANGLE plc - Cash Flow Conversion Efficiency Trend (2000–2024)
This chart illustrates how ANGLE plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
ANGLE plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ANGLE plc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Firma Oponiarska DĘBICA SA
WAR:DBC
|
0.032x |
|
Lotus Bakeries NV
PINK:LOTBY
|
0.084x |
|
Cardlytics Inc
NASDAQ:CDLX
|
-0.374x |
|
GenoFocus Inc
KQ:187420
|
0.037x |
|
Solasia Pharma K.K
F:9SO
|
-0.243x |
|
Mithril Silver and Gold Ltd
AU:MTH
|
-0.013x |
|
Kpx Green Chem
KO:083420
|
0.108x |
|
Fosterville South Exploration Ltd
OTCQX:FSXLF
|
-0.083x |
Annual Cash Flow Conversion Efficiency for ANGLE plc (2000–2024)
The table below shows the annual cash flow conversion efficiency of ANGLE plc from 2000 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $18.44 Million | $-13.45 Million | -0.729x | -15.70% |
| 2023-12-31 | $22.94 Million | $-14.46 Million | -0.630x | -57.33% |
| 2022-12-31 | $40.06 Million | $-16.05 Million | -0.401x | -15.32% |
| 2021-12-31 | $40.33 Million | $-14.01 Million | -0.347x | -52.02% |
| 2020-12-31 | $34.34 Million | $-7.85 Million | -0.229x | +39.59% |
| 2018-12-31 | $19.34 Million | $-7.31 Million | -0.378x | +11.80% |
| 2017-12-31 | $15.88 Million | $-6.81 Million | -0.429x | +48.85% |
| 2016-12-31 | $8.81 Million | $-7.38 Million | -0.838x | +7.83% |
| 2015-12-31 | $5.24 Million | $-4.76 Million | -0.910x | -168.19% |
| 2014-12-31 | $10.09 Million | $-3.42 Million | -0.339x | +16.30% |
| 2013-12-31 | $5.51 Million | $-2.23 Million | -0.405x | -97.56% |
| 2012-12-31 | $6.79 Million | $-1.39 Million | -0.205x | +16.39% |
| 2011-12-31 | $4.41 Million | $-1.08 Million | -0.245x | -37.30% |
| 2010-12-31 | $4.53 Million | $-810.00K | -0.179x | -61.09% |
| 2009-12-31 | $4.16 Million | $-461.00K | -0.111x | +46.35% |
| 2008-12-31 | $3.82 Million | $-790.00K | -0.207x | +34.06% |
| 2007-12-31 | $7.22 Million | $-2.26 Million | -0.314x | +71.32% |
| 2006-12-31 | $5.70 Million | $-6.23 Million | -1.093x | -303.88% |
| 2005-12-31 | $14.48 Million | $-3.92 Million | -0.271x | 0.00% |
| 2004-12-31 | $14.48 Million | $-3.92 Million | -0.271x | -5819.15% |
| 2003-12-31 | $10.99 Million | $52.00K | 0.005x | +100.44% |
| 2002-12-31 | $546.00K | $-592.00K | -1.084x | +4.59% |
| 2001-12-31 | $909.00K | $-1.03 Million | -1.136x | -23.10% |
| 2000-12-31 | $1.30 Million | $-1.20 Million | -0.923x | -- |